Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Immune Assessment of PD-1 Antibody Therapy in Tumor - A Case-Control Study

NCT06693440 is registered in ClinicalTrials.gov with Quanli Gao as lead sponsor.

NCT NCT06693440
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06693440 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Immune Assessment of PD-1 Antibody Therapy in Tumor - A Case-Control Study
Lead sponsor
Quanli Gao
Phase
Observational
Overall status
Recruiting
Start date
July 1, 2021
Completion date
November 13, 2030
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adverse event, efficacy, team